- $67.94m
- $118.00m
- $81.67m
Brief: Akoya Biosciences Q3 Gross Margin 62.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Akoya’s Spatial Proteomics Platforms Selected For Use By UK-Based Manifest Consortium To Cancer Immunotherapy
Brief: Akoya Biosciences Announces Scott Mendel As Chairman Of The Board Of Directors
U.S. RESEARCH ROUNDUP-Allstate, Bluebird Bio, Vicinity Motor
U.S. RESEARCH ROUNDUP- Apollo, Blackstone, Hershey
U.S. RESEARCH ROUNDUP- Actinium Pharmaceuticals, Albemarle, ArcBest
Brief: Akoya Biosciences Q2 Revenue USD 23.2 Million Vs. IBES Estimate USD 23.6 Million
Akoya Biosciences up after Craig-Hallum starts with 'buy' rating
U.S. RESEARCH ROUNDUP- Akoya Biosciences, Boston Beer Company, Victory Capital Holdings
Akoya Biosciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 46%
Akoya Biosciences Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
Brief: Akoya Biosciences And Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval For KR-HT5 In China
Akoya Biosciences Inc reports results for the quarter ended in December - Earnings Summary
U.S. RESEARCH ROUNDUP-Bark, Fleetcor Technologies, Tesla
Brief: Akoya Provides Full Year 2024 Financial Outlook
Brief: Akoya Biosciences Q4 Revenue USD 26.5 Million Vs. IBES Estimate USD 25.9 Million